Vnitr Lek 2015, 61(10):873-876

Subclinical thyroid disease

Václav Zamrazil1,2
1 Endokrinologický ústav Praha, ředitelka doc. RNDr. Běla Bendlová, CSc.
2 Subkatedra endokrinologie IPVZ Praha, vedoucí subkatedry prof. MUDr. Václav Zamrazil, DrSc.

Importance of subclinical thyroid disease (STh) is now a matter of discussion. Definition of this unit is laboratory: in presence of normal level of thyroxine (T4) TSH value is changed: in lower TSH level the subclinical hyperthyroidism (STx) in increase TSH levels subclinical hypothyroidism (SH) is present. Risk of clinical manifestation is twoo three times highter in comparison with persons with normal TSH level. Clinical importance STh is still not evaluated definitively. SH caused disturbance of lipid metabolism, elasticity of vessels and endothelial function and therefore increases risk of atherosclerosis. STx causes electrical instability of myocardium with increased risk of arythmias, increases risk of osteoporosis and other changes. Most important are effects of STh in cardiology, reproductive medicine and gynecology. Clinical significance of these effects is not definitively evaluated.

Keywords: atherosclerosis; gynecology risks; hyperthyroidism; hypothyroidism; pregnancy risks; subclinical thyroid disease

Received: September 7, 2015; Accepted: September 25, 2015; Published: October 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zamrazil V. Subclinical thyroid disease. Vnitr Lek. 2015;61(10):873-876.
Download citation

References

  1. Dvořáková M, Hill M, Čerovská J et al. Vliv saturace jodem na výskyt tyreopatií ve vybraných regionech u dospělé populace České republiky. Vnitř Lék 2010; 56(12): 1262-1270. Go to PubMed...
  2. Zimmermann MB, Andersson M. Assessment of iodine nutrition in populations: past, present, and future. Nutr Rev 2012; 70(10): 553-570. Go to original source... Go to PubMed...
  3. Kahaly GY, Dienes HP, Beyer J et al. Iodide induces thyroid autoimmunity in patients with endemic goitre: a randomised, double-blind, placebo-controlled trial. Eur J Endocrinol 1998; 139(3): 290-297. Go to original source... Go to PubMed...
  4. Pedersen IB, Knudsen N, Jorgensen T et al. Thyroid peroxidase and thyroglobulin autoantibodies in a large survey of populations with mild and moderate iodine deficiency. Clin Endocrinol (Oxf) 2003; 58(1): 36-42. Go to original source... Go to PubMed...
  5. Taylor PN, Lazarus JH. Subclinical hypothyroidism in pregnancy. What next after CATS? Thyroid Int 2014; 2: 1-16. Dostupné z WWW: <http://www.thyrolink.com/merck_serono_thyrolink/en/images/Thyroid_Inter_2_2014_NEU_WEB_tcm1553_129405.pdf?Version=>.
  6. Bliddal S, Feldt-Rassmussen N. Protilátky proti tyreoidální peroxidáze jako rizikový faktor v těhotenství. Thyroid Int (české vydání) 2015; 3: 1-39.
  7. Mammen JS, McGready J, Oxman R et al. Thyroid Hormone Therapy and Risk of Thyrotoxicosis in Community-Resident Older Adults: Findings from the Baltimore Longitudinal Study of Aging. Thyroid 2015; 25(9): 979-986. Go to original source... Go to PubMed...
  8. Zhao M, Yang T, Chen Let al. Subclinical hypothyroidism might worsen the effects of aging on serum lipid profiles: a population-based case-control study. Thyroid 2015; 25(5): 485-493. Go to original source... Go to PubMed...
  9. Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev 2008; 29(1): 76-131. Go to original source... Go to PubMed...
  10. Duntas LH, Brenta G. The effect of thyroid disorders on lipid levels and metabolism. Med Clin North Am 2012; 96(2): 269-281. Go to original source... Go to PubMed...
  11. Lioudaki E, Mavroeidi NG, Mikhailidis DP et al. Subclinical hypothyroidism and vascular risk: an update. Hormones (Athens) 2013; 12(4): 495-506. Go to original source... Go to PubMed...
  12. Pearce EN. Update in lipid alteration in subclinical hypothyroidism. J Clin Endocrinol Metab 2012; 97(2): 326-333. Go to original source... Go to PubMed...
  13. Canaris GJ, Manowitz NR, Mayor G et al. The Colorado thyroid disease prevalence study. Arch Intern Med 2000; 160(4): 526-534. Go to original source... Go to PubMed...
  14. Pasqualetti G, Tognini S, Polini A et al. Is subclinical hypothyroidism a cardiovascular risk factor in the elderly? J Clin Endocrinol Metab 2013; 98(6): 2256-2266. Go to original source... Go to PubMed...
  15. Meier C, Staub JJ, Roth CB et al. TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study). J Clin Endocrinol Metab 2001; 86(10): 4860-4866. Go to original source... Go to PubMed...
  16. Asvold BO, Bjøro T, Platou C et al. Thyroid function and the risk of coronary heart disease: 12-year follow-up of the HUNT study in Norway. Clin Endocrinol (Oxf) 2012; 77(6): 911-917. Go to original source... Go to PubMed...
  17. Liu H, Shan Z, Li C et al. Maternal subclinical hypothyroidism thyroid autoimmunity and risk of miseatiage: a prospective cohort study. Thyroid 2014; 24(11): 1642-1649. Go to original source... Go to PubMed...
  18. Joung JY, Cho YY, Park SM et al. Effect of iodine restriction on thyroid function in subclinical hypothyroid patients in an iodine-replete area: a long period observation in a large-scale cohort. Thyroid 2014; 24(9): 1361-1368. Go to original source... Go to PubMed...
  19. Zimmermann MB, Jooste PL, Pandav CJ. Iodine-deficiency disorders. Lancet 2008; 372(9645): 1251-1262. Go to original source... Go to PubMed...
  20. Yoon SY, Choi SR, Kim DM et al. The effect of iodine restriction on thyroid function in patients with hypothyroidism due to Hashimoto's thyroiditis. Yonsei Med J 2003; 44(2): 227-235. Go to original source... Go to PubMed...
  21. Leung AM, Braverman LE. Consequences of excess iodine. Nat Rev Endocrinol 2014; 10(3): 136-142. Go to original source... Go to PubMed...
  22. Rassoly L, Burek CL, Rose NR. Iodine-induced autoimmune thyroiditis in NOD-H-2h4 mice. Clin Immunolog Immunopathol 1996; 81(3): 287-292. Go to original source... Go to PubMed...
  23. Maor E, Kivity S, Kopal E et al. Differences in heart rate profile during exercice among subjects with subclinical thyroid disease. Thyroid 2013; 23(10): 1226-1232. Go to original source... Go to PubMed...
  24. Biondi B, Palmieri EA, Fazio S et al. Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. J Clin Endocrinol Metab 2000; 85(12): 4701-4705. Go to original source...
  25. Biondi B, Palmieri EA, Lombardi G et al. Effects of subclinical thyroid dysfunction on the heart. Ann Intern Med 2002; 137(11): 904-914. Go to original source... Go to PubMed...
  26. Brenta G, Mutti LA, Schnitman H et al. Assessment of left ventricular diastolic function by radionuclide ventriculography at rest and exercise in subclinical hypothyroidism, and its response to L-thyroxine therapy. Am J Cardiol 2003; 91(11): 1327-1330. Go to original source... Go to PubMed...
  27. Rosario PW, Calsolari MG. How selective are the new guidelines for treatment of subclinical hypothyroidism for patients with thyrotropin levels at or below 10 mIU/L? Thyroid 2013; 23(5): 562-565. Go to original source... Go to PubMed...
  28. Giri A, Edwards TL, LeGrys VA et al. Subclinical hypothyroidism and risk for incident ischemic stroke among postmenopausal women. Thyroid 2014; 24(8): 2010-2017. Go to original source... Go to PubMed...
  29. Lazarus J, Brown R, Daumerie C et al. 2014 European thyroid association guidelines for the management of subclinical hypothyroidism in pregnancy and in children. Eur Thyr J 2014; 3(2): 76-94. Go to original source... Go to PubMed...
  30. Stagnaro-Green A, Abalovich M, Alexander E et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 2011; 21(10): 1081-1125. Go to original source... Go to PubMed...
  31. Teng W, Shzu Z. Pregnancy and thyroid diseases in China. Thyroid 2011; 21(10): 1053-1055. Go to original source... Go to PubMed...
  32. Haddow JE. Thyroid Study Group. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol 2005; 106(1): 198. Go to original source... Go to PubMed...
  33. Krassas GF, Poppe K, Glinoer D. Thyroid function and human reproductive health. Endocr Rev 2010; 31(5): 702-755. Go to original source... Go to PubMed...
  34. Männistö T, Mendola P, Grewal J et al. Thyroid diseases and adverse pregnant outcomer in contemporaly US cohort. J Clin Endocrinol Metab 2013; 98(7): 2725-2733. Go to original source... Go to PubMed...
  35. Wilson KL, Casey BM, Melutize DT et al. Subclinical thyroid disease and the incidence of hypertension in pregnancy. Obstred Gynecol 2012; 119(2 Pt1): 315-320. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.